Keywords
Bone metastasis
Mechanism
Bone targeting drugs
Cancer cell
Submitted : 2024-07-14
Accepted : 2024-07-29
Published : 2024-08-13
Abstract
Prostate cancer is a common male malignant tumor, and bone metastasis is one of the common complications in the late stage of prostate cancer. The mechanism of prostate cancer bone metastasis is a complex process involving multiple factors and steps. In recent years, with in-depth research on the mechanism of prostate cancer bone metastasis and the development of new drugs, important progress has been made in the treatment of prostate cancer bone metastasis. Based on this, this article introduces the mechanism of prostate cancer bone metastasis and the research progress of several bone-targeted drugs to provide reference and inspiration for future research.
References
Zhou Q, Tian X, Chang D, et al., 2022, Chinese Expert Consensus on Prostate Cancer Diagnosis, Treatment, and Health Management Using Integrated Traditional Chinese and Western Medicine. Chinese Journal of Andrology, 28(10): 941–953.
Chen W, Zheng R, Baade PD, et al., 2016, Cancer Statistics in China, 2015. CA Cancer J Clin, 66(2): 115–132. https://doi.org/10.3322/caac.21338
Tian Z, Heng L, Dong J, et al., 2023, Bioinformatics Analysis of Key Genes for Prostate Cancer Bone Metastasis. Chinese Journal of Immunology, 39(9): 1885–1892.
Duan X, Cui Y, 2023, Progress in Diagnosis and Treatment of Prostate Cancer Bone Metastasis. Chinese Medical Journal, 58(6): 594–596.
Li X, Chen B, Wu J, et al., 2023, Clinical Study of Denosumab in the Treatment of Prostate Cancer Bone Metastasis Pain. Modern Chinese Physicians, 61(18): 14–17 + 56.
Chen C, Zhou J, Xiang S, 2021, Hot Spots, Challenges, and Opportunities in Diagnosing and Treating Prostate Cancer Bone Metastasis. Journal of Modern Genitourinary Oncology, 13(6): 321–324 + 335.
Gupta N, Duda DG, 2016, Role of Stromal Cell-Derived Factor 1Alpha Pathway in Bone Metastatic Prostate Cancer. J Biomed Res, 30(3): 181–185. https://doi.org/10.7555/JBR.30.20150114
Conley-LaComb MK, Semaan L, Singareddy R, et al., 2016, Pharmacological Targeting of CXCL12/CXCR4 Signaling in Prostate Cancer Bone Metastasis. Mol Cancer, 15(1): 68. https://doi.org/10.1186/s12943-016-0552-0
Sun B, Liu J, Cai T, et al., 2018, Analysis of the Correlation Between Serum TGF-Beta1, VEGF, and IL-6 Levels and Prostate Cancer Bone Metastasis. Journal of Clinical and Experimental Medicine, 17(19): 2086–2089.
Mao L, Wu W, Huang Y, et al., 2021, Expression Levels and Clinical Significance of PSA, IL-6, TNF-Alpha, and IL-17A in Peripheral Blood of Patients with Prostate Cancer. Chinese Medical Equipment, 18(2): 77–81.
Deng X, He G, Liu J, et al., 2014, Recent Advances in Bone-Targeted Therapies of Metastatic Prostate Cancer. Cancer Treat Rev, 40(6): 730–738. https://doi.org/10.1016/j.ctrv.2014.04.003
Ye L, Kynaston HG, Jiang WG, 2007, Bone Metastasis in Prostate Cancer: Molecular and Cellular Mechanisms (Review). Int J Mol Med, 20(1): 103–111.
Zhang X, 2019, Interactions Between Cancer Cells and Bone Microenvironment Promote Bone Metastasis in Prostate Cancer. Cancer Commun (Lond), 39(1): 76. https://doi.org/10.1186/s40880-019-0425-1
He Z, Du D, Fu H, et al., 2020, Research Progress on the Correlation Between the Wnt Signaling Pathway and Prostate Cancer. Chinese Journal of Laparoscopic Urology (Electronic Edition), 14(4): 312–315.
Liao Z, Liang C, Chen C, et al., 2021, The Effect of Alkaloids on Prostate Cancer Bone Metastasis PC-3 Cells Through the Wnt/Beta-Catenin Signaling Pathway. Journal of Practical Medicine, 37(3): 298–303.
Peng W, Fan C, Zhang H, 2020, The Impact of HIF-1Alpha on Immune Escape of A549 Lung Cancer Cells and the NCR1/NKP46 Pathway by Regulating miR-544. Journal of Clinical Pulmonology, 25(8): 1246–1251.
Zhou R, Guo Z, Yang J, et al., 2023, Study on the Mechanism of miR-335-5p Targeting Galectin-3 to Regulate Immune Escape of Prostate Cancer Cells. Modern Oncology, 31(13): 2431–2437.
Huang L, He J, 2020, Research Progress on PD-1/PD-L1 Inhibitors and Prostate Cancer Immunotherapy. Chinese Journal of Andrology, 26(10): 944–948.
Fan H, Lai Y, Zhou J, et al., 2023, High Expression of RAI14 Promotes Bone Metastasis of Prostate Cancer and is Associated with Poor Prognosis. Lingnan Modern Clinical Surgery, 23(2): 127–134.
Han Y, Ren M, 2023, Research Progress on Prostate Cancer Bone Metastasis Mechanism and Bone-Targeted Drugs. Journal of Practical Oncology, 37(3): 252–256.
Yang X, Li X, Wu K, et al., 2022, Preliminary Study on the Treatment of Bone Metastasis of Prostate Cancer with Radium-223. Journal of Modern Urology, 27(2): 133–136.
Sun H, Zhao G, Yan P. 223Ra Injection in the Treatment of Bone Metastasis and Castration-Resistant Prostate Cancer Caused by Radiation Effects. Chinese Interventional Imaging and Therapeutics, 19(9): 575–578.
Hong L, 2021, Clinical Effect of Strontium Chloride [89Sr] Injection in the Treatment of Prostate Cancer Bone Metastasis Pain. Chinese and Foreign Medical Research, 19(34): 152–155.
Shan Y, 2019, Treatment of Prostate Cancer Bone Metastasis with Radionuclide 89Sr. Chinese and Foreign Medicine, 38(22): 184–186.
Yu X, Kong W, 2012, Bisphosphonates and the Treatment of Giant Cell Tumor of Bone. Chinese Journal of Clinicians (Electronic Edition), 6(17): 4991–4994.
Cao S, 2018, The Efficacy and Nursing Care of Diphosphonates in Treating Bone Pain in Patients with Metastatic Bone Tumors. Strait Pharmacy, 30(2): 213–214.
Miao Z, Zhu X, 2018, Observation on the Efficacy of 99 Technetium-Methylene Diphosphonate in the Treatment of Prostate Cancer Bone Metastasis. Guangzhou Medicine, 49(3): 94–96.
Zhang Q, Yan S, 2012, Analysis of the Efficacy of 99 Technetium-Methylene Diphosphate in the Treatment of Osteoporosis. Chinese Journal of Practical Diagnosis and Treatment, 26(4): 380–381.
Liu Y, Lu J, 2009, A Systematic Review of Bisphosphonates in the Treatment of Prostate Cancer Bone Metastasis. Chinese Journal of Andrology, 23(8): 33–37 + 44.